Humacyte Inc (HUMA) Insider Trading
- $588,510.20
- $64,134,063.03
- Sept. 10, 2024
- Laura E Niklason
Trader Name | Date | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|---|
Sept. 10, 2024 | Director | 5,182 | $5.40 | Sell | $27,982.80 | |
Sept. 9, 2024 | CEO | 157,704 | $5.42 | Sell | $854,755.68 | |
Aug. 29, 2024 | Director | 352,112 | $6.35 | Sell | $2,235,911.20 | |
Aug. 28, 2024 | CEO | 277,090 | $6.47 | Sell | $1,792,772.30 | |
Aug. 27, 2024 | CFO | 39,389 | $6.68 | Sell | $263,118.52 | |
Aug. 27, 2024 | Director | 252,676 | $6.71 | Sell | $1,695,455.96 | |
June 12, 2024 | Director | 271,518 | $7.30 | Sell | $1,982,081.40 | |
June 11, 2024 | CEO | 358,630 | $7.08 | Sell | $2,539,100.40 | |
June 4, 2024 | Director | 2,362 | $6.35 | Buy | $14,998.70 | |
June 3, 2024 | CEO | 2,050 | $7.37 | Buy | $15,108.50 | |
May 31, 2024 | CEO | 809,786 | $7.91 | Sell | $6,405,407.26 | |
May 30, 2024 | COO | 188,886 | $8.14 | Sell | $1,537,532.04 | |
May 15, 2024 | Director | 50,000 | $6.78 | Buy | $339,000.00 | |
Sept. 14, 2023 | CEO | 2,000,000 | $2.78 | Sell | $5,560,000.00 | |
Aug. 21, 2023 | CEO | 602,443 | $3.39 | Sell | $2,042,281.77 | |
Aug. 18, 2023 | Director | 626,979 | $3.57 | Sell | $2,238,315.03 | |
Aug. 17, 2023 | CEO | 570,174 | $3.68 | Sell | $2,098,240.32 | |
June 15, 2023 | CEO | 500,000 | $3.12 | Sell | $1,560,000.00 | |
June 13, 2023 | CEO | 4,875,000 | $2.60 | Sell | $12,675,000.00 | |
May 25, 2023 | CEO | 2,625,000 | $2.75 | Sell | $7,218,750.00 | |
May 25, 2023 | COO | 9,613 | $3.83 | Sell | $36,817.79 | |
Dec. 16, 2022 | Director | 239,538 | $2.53 | Sell | $606,031.14 | |
Dec. 16, 2022 | CFO | 20,000 | $2.60 | Buy | $52,000.00 | |
Dec. 15, 2022 | CEO | 93,426 | $2.63 | Sell | $245,710.38 | |
Dec. 14, 2022 | Director | 276,304 | $2.76 | Sell | $762,599.04 | |
Dec. 13, 2022 | CEO | 330,000 | $2.84 | Sell | $937,200.00 | |
Dec. 13, 2022 | Insider | 5,000 | $3.09 | Buy | $15,450.00 | |
Sept. 15, 2022 | Director | 1,522,500 | $4.00 | Sell | $6,090,000.00 | |
Sept. 15, 2022 | CEO | 2,000 | $4.14 | Buy | $8,280.00 | |
May 24, 2022 | Insider | 10,525 | $4.72 | Buy | $49,678.00 | |
May 23, 2022 | CEO | 10,000 | $4.83 | Buy | $48,300.00 | |
May 23, 2022 | Director | 2,000 | $4.83 | Buy | $9,660.00 | |
May 17, 2022 | CFO | 2,000 | $4.53 | Buy | $9,060.00 | |
Dec. 16, 2021 | Director | 75,000 | $9.00 | Sell | $675,000.00 | |
Dec. 15, 2021 | CEO | 125,000 | $8.88 | Sell | $1,110,000.00 | |
Dec. 14, 2021 | Director | 100,000 | $9.44 | Sell | $944,000.00 | |
Nov. 22, 2021 | Director | 2,500 | $10.79 | Buy | $26,975.00 |
Insiders are both buying and selling Humacyte Inc stock.
The insider traders at Humacyte Inc are: Laura E Niklason, Brady W Dougan, Dale A Sander, William John Scheessele, Heather Ledbetter Prichard, Michael T Constantino, Gordon M Binder, and Kathleen Sebelius
The most active insider trader at Humacyte Inc is Laura E Niklason with 16 trades.
Laura E Niklason has sold the most Humacyte Inc stock with a total value of $45,893,973.79.
Gordon M Binder has bought the most Humacyte Inc stock with a total value of $678,000.00.
The most recent insider trade for Humacyte Inc was on Sept. 10, 2024.
The single biggest insider buy for Humacyte Inc was from Gordon M Binder with a total value of $339,000.00 on May 15, 2024.
The single biggest insider sell for Humacyte Inc was from Laura E Niklason with a total value of $12,675,000.00 on June 13, 2023.